Dialysis fistula or graft: The role for randomized clinical trials

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 12, 2010, Pages 2348-2354

  Allon, Michael ^a   Lok, Charmaine E ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FISH OIL; HEMOGLOBIN; PLACEBO;

ARTERY GRAFT; BACTEREMIA; BLOOD VESSEL DIAMETER; BRACHIOCEPHALIC TRUNK; BRACHIOCEPHALIC VEIN; CANNULATION; CATHETER COMPLICATION; CENTRAL VEIN; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DIALYSIS; DIALYSIS CATHETER; GRAFT FAILURE; GRAFT PATENCY; GRAFT SURVIVAL; HEALTH CARE COST; HEMODIALYSIS PATIENT; HUMAN; HYPEREMIA; KIDNEY ARTERIOVENOUS FISTULA; LIFE EXPECTANCY; NEPHROLOGIST; NONHUMAN; POSTOPERATIVE CARE; QUALITY OF LIFE; REVIEW; SURGICAL THROMBECTOMY; THROMBOSIS; VASCULAR ACCESS; VEIN GRAFT; VEIN OCCLUSION;

ARTERIOVENOUS SHUNT, SURGICAL; CATHETERS, INDWELLING; FOREARM; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; VASCULAR PATENCY;

EID: 78650346570     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06050710     Document Type: Review

References (59)

1. Allon M: Current management of vascular access. Clin J Am Soc Nephrol 2: 786-800, 2007
2. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ: Vascular access use in Europe and in the United States: Results from the DOPPS. Kidney Int 61: 305-316, 2002
3. Spergel LM: Has the Fistula First Breakthrough Initiative caused an increase in catheter prevalence? Semin Dial 21: 550-552, 2008
4. Collins AJ, Foley RN, Gilbertson DT, Chen SC: The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol 4[Suppl 1]: S5-S11, 2009
5. Lee T, Barker J, Allon M: Tunneled catheters in hemodialysis patients: Reasons and subsequent outcomes. Am J Kidney Dis 46: 501-508, 2005
6. Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, Canaud BJ, Pisoni RL: Vascular access use and outcomes: An international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 23: 3219-3226, 2008
7. Konner K, Hulbert-Shearon TE, Roys EC, Port FK: Tailoring the initial vascular access for dialysis patients. Kidney Int 62: 329-338, 2002
8. Kinnaert P, Vereerstraeten P, Toussaint C, Van Geertruyden J: Nine years' experience with internal arteriovenous fistulas for haemodialysis: A study of some factors influencing the results. Br J Surg 64: 242-246, 1977
9. Reilly DT, Wood RFM, Bell PRF: Prospective study of dialysis fistulas: Problem patients and their treatment. Br J Surg 69: 549-553, 1982
10. Bonalumi U, Civalleri D, Rovida S, Adami GF, Gianetta E, Griffanti-Bartoli F: Nine years' experience with end-to-end arteriovenous fistula at the "anatomic snuffbox" for maintenance hemodialysis. Br J Surg 69: 486-488, 1982
11. Allon M, Robbin ML: Increasing arteriovenous fistulas in hemodialysis patients: Problems and solutions. Kidney Int 62: 1109-1124, 2002
12. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, Himmelfarb J, Vazquez MA, Gassman JJ, Greene T, Radeva MK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS, Meyers CM, Kusek JW, Feldman HI: Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis. JAMA 299: 2164-2171, 2008
13. Huijbregts HJ, Bots ML, Wittens CH, Schrama YC, Moll FL, Blankestijn PJ: Hemodialysis arteriovenous fistula patency revisited: Results of a prospective, multicenter initiative. Clin J Am Soc Nephrol 3: 714-719, 2008
14. Lok CE, Allon M, Moist LM, Oliver MJ, Shah H, Zimmerman D: REDUCE FTM I (Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas). J Am Soc Nephrol 17: 3204-3212, 2006
15. Peterson WJ, Barker J, Allon M: Disparities in fistula maturation persist despite preoperative vascular mapping. Clin J Am Soc Nephrol 3: 437-441, 2008
16. KDOQI clinical practice guidelines and clinical practice recommendations for vascular access 2006. Am J Kidney Dis 48[Suppl 1]: S176-S322, 2006
17. Allon M, Lockhart ME, Lilly RZ, Gallichio MH, Young CJ, Barker J, Deierhoi MH, Robbin ML: Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int 60: 2013-2020, 2001
18. Korten E, Toonder IM, Schrama YC, Hop WC, van der Ham AC, Wittens CH: Dialysis fistulae patency and preoperative diameter ultrasound measurements. Eur J Vasc Endovasc Surg 33: 467-471, 2007
19. Brown PW: Preoperative radiological assessment for vascular access. Eur J Vasc Endovasc Surg 31: 64-69, 2006
20. Maya ID, O'Neal JC, Young CJ, Barker-Finkel J, Allon M: Outcomes of brachiocephalic fistulas, transposed brachiobasilic fistulas, and upper arm grafts. Clin J Am Soc Nephrol 4: 86-92, 2009
21. Wells AC, Fernando B, Butler A, Huguet E, Bradley JA, Pettigrew GJ: Selective use of ultrasonographic vascular mapping in the assessment of patients before haemodialysis access surgery. Br J Surg 92: 1439-1443, 2005
22. Jennings WC: Creating arteriovenous fistulas in 132 consecutive patients: exploiting the proximal radial artery arteriovenous fistula: reliable, safe, and simple forearm and upper arm hemodialysis access. Arch Surg 141: 27-32, 2006
23. Choi KL, Salman L, Krishnamurthy G, Mercado C, Merrill D, Thomas I, Artikov S, Contreras G, Khan RA, Warda A, Asif A: Impact of surgeon selection on access placement and survival following preoperative mapping in the "Fistula First" era. Semin Dial 21: 341-345, 2008
24. Fassiadis N, Morsy M, Siva M, Marsh JE, Makanjuola AD, Chemla ES: Does the surgeon's experience impact on radiocephalic fistula patency rates? Semin Dial 20: 455-457, 2007
25. Hossny A: Brachiobasilic arteriovenous fistula: different surgical techniques and their effects on fistula patency and dialysis-related complications. J Vasc Surg 37: 821-826, 2003
26. Biuckians A, Scott EC, Meier GH, Panneton JM, Glickman MH: The natural history of autologous fistulas as first-time dialysis access in the KDOQI era. J Vasc Surg 47: 415-421, 2008 (Pubitemid 351172675)
27. Falk A: Maintenance and salvage of arteriovenous fistulas. J Vasc Interv Radiol 17: 807-813, 2006
28. Huber TS, Ozaki CK, Flynn TC, Lee WA, Berceli SA, Hirneise CM, Carlton LM, Carter JW, Ross EA, Seeger JM: Prospective validation of an algorithm to maximize native arteriovenous fistulae for chronic hemodialysis access. J Vasc Surg 36: 452-459, 2002
29. Rooijens PP, Burgmans JP, Yo TI, Hop WC, de Smet AA, van den Dorpel MA, Fritschy WM, de Groot HG, Burger H, Tordoir JH: Autogenous radial-cephalic or prosthetic brachial-antecubital forearm loop AVF in patients with compromised vessels? A randomized, multicenter study of the patency of primary hemodialysis access. J Vasc Surg 42: 481-487, 2005 (Pubitemid 41323836)
30. Mishler R, Sands JJ, Ofsthun NJ, Teng M, Schon D, Lazarus JM: Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments. Kidney Int 69: 393-398, 2006 (Pubitemid 43323093)
31. Beathard GA, Settle SM, Shields MW: Salvage of the nonfunctioning arteriovenous fistula. Am J Kidney Dis 33: 910-916, 1999
32. Ohira S, Kon T, Imura T: Evaluation of primary failure in native AV-fistulae (early fistula failure). Hemodial Int 10: 173-179, 2006
33. Dixon BS, Novak L, Fangman J: Hemodialysis vascular access survival: Upper-arm native arteriovenous fistula. Am J Kidney Dis 39: 92-101, 2002 (Pubitemid 34062501)
34. Lok CE, Oliver MJ, Su J, Bhola C, Hannigan N, Jassal SV: Arteriovenous fistula outcomes in the era of the elderly dialysis population. Kidney Int 67: 2462-2469, 2005 (Pubitemid 41623411)
35. Miller A, Holzenbein TJ, Gottlieb MN, Sacks BA, Lavin PT, Goodman WS, Gupta SK: Strategies to increase the use of autogenous arteriovenous fistula in end-stage renal disease. Ann Vasc Surg 11: 397-405, 1997 (Pubitemid 27295188)
36. Rajan DK, Bunston S, Misra S, Pinto R, Lok CE: Dysfunctional autogenous hemodialysis fistulas: Outcomes after angioplasty - Are there clinical predictors of patency? Radiology 232: 508-515, 2004 (Pubitemid 38971293)
37. Fitzgerald JT, Schanzer A, Chin AI, McVicar JP, Perez RV, Troppmann C: Outcomes of upper arm arteriovenous fistulas for maintenance hemodialysis access. Arch Surg 139: 201-208, 2004 (Pubitemid 38174717)
38. Kaufman JS: Antithrombotic agents and the prevention of access thrombosis. Semin Dialysis 13: 40-46, 2000
39. Irish A, Dogra G, Mori T, Beller E, Heritier S, Hawley Cm, Kerr PG, Robertson A, Rosman J, Paul-Brent PA, Starfield M, Polkinghorne KR, Cass A: Preventing AVF thrombosis: The rationale and design of the omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal disease (FAVOURED) study. BMC Nephrology 10: 1, 2009
40. Dixon BS: Why don't fistulas mature? Kidney Int 70: 1413-1422, 2006
41. Roy-Chaudhury P, Sukhatme VP, Cheung AK: Hemodialysis vascular access dysfunction: A cellular and molecular viewpoint. J Am Soc Nephrol 17: 1112-1127, 2006
42. Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, Dember LM, Himmelfarb J, Gassman JJ, Greene T, Radeva MK, Davisdson IJ, Ikizler TA, Braden GL, Fenves AZ, Kaufman JS, Cotton JR, Martin KJ, McNeil JW, Rahman A, Lawson JH, Whiting JF, Hu B, Meyers CM, Kusek JW, Feldman HI; DAC Study Group: Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med 360: 2191-2201, 2009
43. Lok CE: Fistula first initiative: Advantages and pitfalls. Clin J Am Soc Nephrol 1043-1053, 2007
44. Schild AF, Perez E, Gillaspie E, Seaver C, Livingstone J, Thibonnier A: Arteriovenous fistulae vs. arteriovenous grafts: A retrospective review of 1,700 consecutive vascular access cases. J Vasc Access 9: 231-235, 2008
45. Richardson AI, Leake A, Schmieder GC, Biuckians A, Stokes GK, Panneton JM, Glickman MH: Should fistulas really be first in the elderly patient? J Vasc Access 10: 199-202, 2009
46. Lee T, Barker J, Allon M: Comparison of survival of upper arm arteriovenous fistulas and grafts after failed forearm fistulas. J Am Soc Nephrol 18: 1936-1941, 2007
47. Asif A, Lenz O, Merrill D, Cherla G, Cipleu CD, Ellis R, Francois B, Epstein DL, Pennell P: Percutaneous management of perianastomotic stenosis in arteriovenous fistulae: Results of a prospective study. Kidney Int 69: 1904-1909, 2006
48. Beathard GA, Arnold P, Jackson J, Litchfield T; Physician Operators Forum of RMS Lifeline: Aggressive treatment of early fistula failure. Kidney Int 64: 1487-1494, 2003
49. Nassar GM, Nguyen B, Rhee E, Achkar K: Endovascular treatment of the "failing to mature" arteriovenous fistula. Clin J Am Soc Nephrol 1: 275-280, 2006
50. Singh P, Robbin ML, Lockhart ME, Allon M: Clinically immature arteriovenous hemodialysis fistulas: Effect of US on salvage. Radiology 246: 299-305, 2008 (Pubitemid 350305056)
51. Lee TC, Ullah A, Roy-Chaudhury P: Aggressive interventions for fistula maturation: A double-edged sword? J Vasc Access 11[Suppl 2]: S8, 2010
52. Keuter XH, De Smet AA, Kessels AG, van der Sande FM, Welten RJ, Tordoir JH: A randomized multicenter study of the outcome of brachial-basilic arteriovenous fistula and prosthetic brachial-antecubital forearm loop as vascular access for hemodialysis. J Vasc Surg 47: 395-401, 2008
53. Salman L, Alex M, Unger SW, Contreras G, Lenz O, Asif A: Secondary autogenous arteriovenous fistulas in the "fistula first" era: Results of a long-term prospective study. J Am Coll Surg 209: 100-105, 2009
54. Begin V, Ethier J, Dumont M, Leblanc M: Prospective evaluation of the intra-access flow of recently created native arteriovenous fistulae. Am J Kidney Dis 40: 1277-1282, 2002 (Pubitemid 35403140)
55. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux on mortality and morbidity in maintenance hemodialysis patients: Primary results of the HEMO Study. N Engl J Med 347: 2010-2019, 2002
56. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085-2098, 2006 (Pubitemid 44749317)
57. Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071-2084, 2006 (Pubitemid 44749316)
58. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R: A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361: 2019-2032, 2009
59. Naik AD, Peterson LA: The neglected purpose of comparative-effectiveness research. N Engl J Med 360: 1929-1931, 2009